GARDEN CITY HOSPITAL OSTEOPATHIC — History
CCN 230244 | 3-year financial timeline | COVID resilience: 33/100
🛡️ Public data only — no PHI permitted on this instance.
$148M
Latest Revenue (FY2022)
-1.3%
Revenue CAGR (3yr)
11.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $152M | $124M | $148M | +19.2% | -1.3% |
| Operating Expenses | $118M | $118M | $131M | +10.5% | +5.5% |
| Operating Margin | 22.5% | 4.6% | 11.5% | +149.8% | -28.5% |
| Net Income | $34M | $6M | $17M | +197.7% | -29.5% |
| Licensed Beds | 146 | 146 | 151 | +3.4% | +1.7% |
| Total Patient Days | 32,742 | 29,612 | 33,411 | +12.8% | +1.0% |
| Medicare Day % | 34% | 32% | 27% | -14.5% | -10.8% |
| Medicaid Day % | 4% | 6% | 6% | +2.7% | +12.6% |
COVID Impact & Recovery
Resilience Score: 33/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -2.6% ($152M → $148M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-1.3%
This Hospital
+7.6%
State Avg
Latest Margin
11.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $146M | 6.0% |
| FY2024 (proj) | $144M | 0.5% |
| FY2025 (proj) | $142M | -5.0% |